pentobarbital will lower the extent or impact of gefitinib by impacting hepatic/intestinal enzyme CYP3A4 metabolism.The usage of barbiturates as sedatives from the postoperative surgical period and as adjuncts to cancer chemotherapy is effectively provenWith therapeutic doses of TCAs, barbiturates raise metabolism and reduce blood concentrations of